Clinical trial
Safety and Efficacy of the Infinnium-Core™ Paclitaxel-Eluting Coronary Stent System for the Treatment of Patients With De Novo Coronary Lesions
NCT00936780 is registered in ClinicalTrials.gov with Sahajanand Medical Technologies Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of the Infinnium-Core™ Paclitaxel-Eluting Coronary Stent System for the Treatment of Patients With De Novo Coronary Lesions
- Lead sponsor
- Sahajanand Medical Technologies Limited
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2008
- Completion date
- March 31, 2011
- Enrollment
- 67 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.